Bioinformatics analysis of lung cancer metastasis-related miR-29b

Chinese Journal of Clinical Oncology

Volumn 41, Issue 16, 2014, Pages 1021-1025

  Wang, Hongyan ^a   Zheng, Shaoqiu ^a   Tu, Yongsheng ^a   Zhang, Yajie ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Bioinformatics; Lung cancer; MiR 29b; Target gene

Indexed keywords

CD133 ANTIGEN; JANUS KINASE; MICRORNA; MICRORNA 29B; STAT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

A549 CELL LINE; ARTICLE; BIOINFORMATICS; CANCER RESEARCH; GENE EXPRESSION; GENE ONTOLOGY; GENE TARGETING; LUNG METASTASIS; POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84908086340     PISSN: 10008179     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1000-8179.20132018     Document Type: Article

References (15)

1. Le XF, Merchant O, Bast RC, et al. The Roles of MicroRNAs in the Cancer Invasion-Metastasis Cascade[J]. Cancer Microenviron, 2010,3(1):137-147.
2. Zheng Q, Wang XJ. GOEAST: a web-based software toolkit for Gene Ontology enrichment analysis[J]. Nucleic Acids Res, 2008, 36 (Web Server issue) :W358-W363.
3. Qti H, Li R, Liu Z, et al. Prognostic value of cancer stem cell marker CD133 expression in non-small cell lung cancer: a systematic re-viewr[J]. IntJ Clin Exp Pathol, 2013, 6(11):2644-2650.
4. Kubo T, Takigawa N, Osawa M, et al. Subpopulation of small-cell lung cancer cells expressing CD133 and CD87 show resistance to chemotherapyt[J]. Cancer Sci, 2013, 104(1)78-84.
5. Fabbri M, Garzon R, Cimmino A, et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyl-transferases 3A and 3B[J]. Proc Natl Acad Sci USA, 2007, 104(40): 15805-15810.
6. Tan M, Wu J. Cai Y. Suppression of Wnt signaling by the miR-29 family is mediated by demethylarion of WIF-1 in non-small-cell lung cancer[J]. Biochem Biophys Res Commun, 2013, 438(4):673-679.
7. Fang JH, Zhou HC, Zeng C, et al. MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix me-talloproteinase 2 expressionfj]. Hepatology, 2011, 54(5):1729-1740.
8. Roderburg C, Urban GW, Bettermann K, et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis[J]. Hepatology, 2011, 53(1):209-218.
9. Cushing L, Kuang PP, QianJ, et al. miR-29 is a major regulator of genes associated with pulmonary fibrosis[J]. Am J Respir Cell Mol Biol, 2011,45(2):287-294.
10. van Rooij E, Sutherland LB, Thatcher JE, et al. Dysregulation of mi-croRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis[J]. Proc Natl Acad Sci USA, 2008, 105(35): 13027-13032.
11. Cortez MA, Nicoloso MS, Shimizu M, et al. miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma[J]. Genes Chromosomes Cancer, 2010,49(11):981-990.
12. Steele R, Mott JL, Ray RB. MBP-1 upregulates miR-29b that represses Mei-1, collagens, and matrix-metalloproteinase-2 in prostate cancer cells[J]. Genes Cancer, 2010, l(4):381-387.
13. Schmitt MJ, Philippidou D, Reinsbach SE, et al. Interferon-γ-induced activation of Signal Transducer and Activator of Transcription 1 (STATI) up-regulates the tumor suppressing microR-NA-29 family in melanoma cells[J]. Cell Commun Signal, 2012, 10 (1):41.
14. Luna C, Li G, Qiu J, et al. Cross-talk between miR-29 and transforming growth factor-betas in trabecular meshwork cells[J]. Invest Ophthalmol Vis Sci, 2011, 52(6):3567-3572.
15. Sterlacci W, Wolf D, Savie S, et al. High transforming growth factor β expression represents an important prognostic parameter for surgically resected non-small cell lung cancer[J]. Hum Pathol, 2012, 43 (3):339-349.